for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Asahi Kasei Corp

3407.T

Latest Trade

1,110.00JPY

Change

7.50(+0.68%)

Volume

3,753,200

Today's Range

1,103.00

 - 

1,111.50

52 Week Range

901.60

 - 

1,765.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
1,102.50
Open
1,109.50
Volume
3,753,200
3M AVG Volume
69.28
Today's High
1,111.50
Today's Low
1,103.00
52 Week High
1,765.00
52 Week Low
901.60
Shares Out (MIL)
1,387.44
Market Cap (MIL)
1,546,385.00
Forward P/E
10.83
Dividend (Yield %)
3.08

Next Event

Dividend For 3407.T - 18.0000 JPY

Latest Developments

More

Zoll Signs Definitive Agreement To Purchase Cardiac Science

Asahi Kasei To Cancel 8,684,300 Treasury Shares Oct 11

Asahi Kasei To Buy Back, Cancel Stock

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Asahi Kasei Corp

ASAHI KASEI CORPORATION is mainly engaged in material business, housing business and others. It has three business segments. The Materials segment includes fiber business, including capra fiber, polyurethane fiber, nonwoven fabric, nylon 66 fiber, etc., chemical business, including petrochemicals, high performance polymer, high performance materials and consumer goods, separators for lithium secondary batteries, separators for lead storage batteries, mixed signal LSI and other electronic businesses. The Housing segment includes housing business, such as construction contracting, real estate, renovation, and other housing related businesses, and the building materials business, including lightweight aerated concrete, heat insulation materials, foundation piles, structural materials, etc. The Healthcare segment consists of pharmaceuticals such as medical drugs and diagnostics, medical business and critical care business. The Company also includes engineering businesses and others.

Industry

Chemical Manufacturing

Contact Info

Hibiya Mitsui Tower, 1-1-2, Yuraku-cho

+81.3.32963000

https://www.asahi-kasei.co.jp/

Executive Leadership

Hideki Kobori

Executive President, President, Representative Director

Masafumi Nakao

Executive Vice President, Representative Director

Yutaka Shibata

Senior Managing Executive Officer, Director

Richard A. Packer

Senior Managing Executive Officer, Chairman of Subsidiary

Shigeki Takayama

Senior Managing Executive Officer, Chief Director of Separator Business

Key Stats

2.77 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

1.9K

2018

2.0K

2019

2.2K

2020(E)

2.2K
EPS (JPY)

2017

82.340

2018

121.930

2019

105.660

2020(E)

101.887
Price To Earnings (TTM)
11.36
Price To Sales (TTM)
0.71
Price To Book (MRQ)
1.14
Price To Cash Flow (TTM)
6.32
Total Debt To Equity (MRQ)
33.86
LT Debt To Equity (MRQ)
17.00
Return on Investment (TTM)
7.76
Return on Equity (TTM)
5.64

Latest News

BRIEF-Asahi Kasei's Group Operating Profit Seen Climbing 20% To Around 190 Bln Yen - Nikkei

* ASAHI KASEI CORP'S GROUP OPERATING PROFIT IS SEEN CLIMBING 20 PERCENT TO AROUND 190 BILLION YEN IN THE FISCAL YEAR ENDING MARCH 31 - NIKKEI

Asahi Kasei unit wins $400 million U.S. defense contract -Pentagon

Zoll Medical Corp, a unit of Asahi Kasei Corp, has been awarded a $400 million contract for deployable vital signs monitors, the Pentagon said on Friday. (Reporting by Mohammad Zargham; Editing by Eric Beech)

BRIEF-Bone Therapeutics and Asahi Kasei sign exclusive license agreement for Preob in Japan

* REG-BONE THERAPEUTICS SA AND ASAHI KASEI SIGN EXCLUSIVE LICENSE AGREEMENT FOR PREOB® IN JAPAN

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up